CIK 0001802768 · Large accelerated filer
Royalty Pharma plc
Sign in to watch- Ticker
- RPRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- (212) 883-0200
- Business address
- 110 EAST 59TH STREET, NEW YORK, NY, 10022
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $12,324,753
- in 4 filings, $12.3M under 10b5-1 plans
Net −$12,324,753. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-01-02 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −20,000 | $38.48 | $770K | 80,000 |
| 2026-01-02 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −65,832 | $38.42 | $2.5M | 460,828 |
| 2026-01-02 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −3,750 | $38.42 | $144K | 39,760 |
| 2025-12-31 | Bassler Bonnie L Director | Grant or award | +967 | $38.74 | $37K | 73,132 |
| 2025-12-26 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −20,000 | $39.32 | $786K | 100,000 |
| 2025-12-19 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −20,000 | $38.38 | $768K | 120,000 |
| 2025-12-18 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −30,654 | $38.50 | $1.2M | 0 |
| 2025-12-17 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −79,346 | $38.57 | $3.1M | 30,654 |
| 2025-12-16 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −20,000 | $38.32 | $766K | 140,000 |
| 2025-12-15 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −65,832 | $38.36 | $2.5M | 526,660 |
| 2025-12-15 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −3,750 | $38.36 | $144K | 43,510 |
| 2025-12-05 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −23,334 | $39.15 | $914K | 160,000 |
| 2025-12-05 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −18,242 | $39.15 | $714K | 7,398 |
| 2025-12-03 | Lloyd George W. EVP, Investments & CLO | Sale 10b5-1 | −110,000 | $39.77 | $4.4M | 110,000 |
| 2025-12-01 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −23,333 | $39.93 | $932K | 183,334 |
| 2025-12-01 | Urist Marshall EVP, Research & Investments | Sale 10b5-1 | −18,242 | $39.90 | $728K | 25,640 |
| 2025-12-01 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −65,832 | $39.87 | $2.6M | 592,492 |
| 2025-12-01 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −3,750 | $39.87 | $149K | 47,260 |
| 2025-11-24 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −55,146 | $38.67 | $2.1M | 669,010 |
| 2025-11-24 | Coyne Terrance P. EVP & CFO | Sale 10b5-1 | −10,686 | $37.96 | $406K | 658,324 |
Page 5 of 8 · 159 trades